Title : Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer.

Pub. Date : 2022 Apr 6

PMID : 35121110






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 While the high-dose testosterone (high-T) treatment is currently being tested in clinical trials of castration-resistant prostate cancer (CRPC), there is still a pressing need to fully understand the underlying mechanism and thus develop treatment strategies to exploit this tumor-suppressive activity of AR. Testosterone androgen receptor Homo sapiens
2 In this study, we demonstrate that retinoblastoma (Rb) family proteins play a central role in maintaining the global chromatin binding and transcriptional repression program of AR, and that Rb inactivation desensitizes CRPC to the high-dose testosterone treatment in vitro and in vivo. Testosterone androgen receptor Homo sapiens